Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Turcot syndrome × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 17 Carcinoma, Non-Small-Cell Lung 15 Esophageal Squamous Cell Carcinoma 14 Breast Neoplasms 12 Triple Negative Breast Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Recurrence 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Sarcoma 4 Neoplasm Metastasis 4 Melanoma 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Renal Cell 4 Rectal Neoplasms 3 Locally Advanced Rectal Cancer 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Microsatellite Stable Metastatic Colorectal Cancer 2 Liver Neoplasms 2 Klatskin Tumor 2

Interventions

Nivolumab 5 pembrolizumab 3 avelumab 3 Neoadjuvant Therapy 3 durvalumab 2 atezolizumab 2 toripalimab 1 spartalizumab 1 relatlimab 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 danvatirsen 1 Surgical Procedures, Operative 1 Oxaliplatin 1 Leucovorin 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 Fluorouracil 1 Docetaxel 1 Disulfides 1 DEAE-Dextran 1 Cyclophosphamide 1 Chemotherapy, Adjuvant 1 Celecoxib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡